Determination of ng/mL Levetiracetam using Ultra-High-Performance Liquid Chromatography-Photodiode Absorbance
Open Access
- 15 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 50 (3), 253-258
- https://doi.org/10.1093/chromsci/bmr053
Abstract
This paper demonstrates the analysis of levetiracetam, a new chiral antiepileptic drug, at ng/mL levels using an ultra-high-performance liquid chromatography (UHPLC)–photodiode absorbance (PDA) method. Three different sample preparation methods, liquid–liquid extraction with Extrelut, solid phase extraction (SPE) with Oasis HLB and Oasis MAX SPE cartridges, and protein precipitation with organic solvents were carried out. The last preparatory method is the simplest and provides the best recoveries: between 97.1% and 100.4% with RSD value below 5%. The column for separation is BEH C18 column (1.7 µm particle size and 100 × 2.1 mm i.d.) and acetonitrile-phosphate buffer (pH = 6.6; 0.01 M) (10/90 v/v) is the mobile phase. The results obtained are compared to analysis conducted by the HPLC method. The UHPLC method was validated in the range of 2–100 µg/mL levetiracetam concentration (R2 = 0.9997). LOD and LOQ are 10 ng/mL and 33 ng/mL, respectively. The developed UHPLC method was applied to plasma samples of patient with epilepsy.This publication has 16 references indexed in Scilit:
- Quantification of levetiracetam in human plasma by liquid chromatography–tandem mass spectrometry: Application to therapeutic drug monitoringJournal of Pharmaceutical and Biomedical Analysis, 2008
- Simple and validated HPLC–UV analysis of levetiracetam in deproteinized plasma of patients with epilepsyJournal of Chromatography B, 2008
- Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometryClinica Chimica Acta; International Journal of Clinical Chemistry, 2007
- Determination of levetiracetam in human plasma with minimal sample pretreatmentJournal of Chromatography B, 2005
- A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phaseJournal of Pharmaceutical and Biomedical Analysis, 2004
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- High‐performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean‐up proceduresBiomedical Chromatography, 2003
- Analysis of the antiepileptic drug keppra by capillary electrophoresisJournal of Chromatography A, 2003
- A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brainBritish Journal of Pharmacology, 2001
- Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000